Navigation Links
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
Date:10/28/2011

lue; 1,000 million shares authorized; and 562.5 million shares issued and outstanding (2010: 1,000 million shares authorized; and 562.2 million shares issued and outstanding) 55.7 55.7 Additional paid-in capital 2,824.5 2,746.4 Treasury stock: 12.5 million shares (2010: 14.0 million) (293.1) (276.1) Accumulated other comprehensive income 88.5 85.7 Retained earnings/(accumulated deficit) 279.1 (160.3) Total equity 2,954.7 2,451.4 Total liabilities and equity 6,065.6 5,387.6

Unaudited US GAAP results for the three months and nine months to September 30, 2011
Consolidated Statements of Income

9 months 3 months to 3 months to 9 months to to September September September September 30, 30, 30, 30, 2011 2010 2011 2010 $M $M $M $M Revenues: Product sales 1,018.4 794.3 2,901.0 2,276.8 Royalties 62.8 76.5 199.8 254.5 Other revenues 4.9 3.5 20.4 8.6 Total revenues 1,086.1 874.3 3,121.2 2,539.9 Costs and expenses: Cost of product sales(1) 166.5 112.7 434.7 333.7 Research and development(1) 201.5 197.9 556.3 475.9 Selling, general and administrative(1) 452.1 392.4 1,295.3 1,106.7 Loss/(gain) on sale of product rights 0.3 - 3.8 (4.1) Reorganization costs 5.0 9.7 18.0 23.3 Integration and acquisition costs 5.3 5.8 7.9 6.4 Total operating expenses 830.7 718.5 2,316.0 1,941.9 Operating income 255.4 155.8 805.2 598.0 Interest income 0.3 1.0 1.5 1.9 Interest expense (9.7) (8.3) (28.8) (25.6) Other income, net 15.6 0.8 15.9 9.0 Total other income/(expense), net 6.2 (6.5) (11.4) (14.7) Income before income taxes and equity in earnings/(losses) of equity method investees 261.6 149.3 793.8 583.3 Income taxes (69.5) (52.7) (187.3) (160.8) Equity in earnings/(losses) of equity method investees, net of taxes 0.8 (0.3) 3.2 0.2 Net income 192.9 96.3 609.7 422.7

(1) Cost of product sales includes amortization of intangible assets relating to favorable manufacturing contracts of $0.5 million f
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), a ... for patients, physicians, the biopharmaceutical industry, regulators, payers, ... signing of a three-year Research Collaboration Agreement (RCA) ... This initiative is designed to generate disruptive ...
(Date:1/14/2014)... UK (PRWEB) January 13, 2014 Bob ... with more than 20 years in the industry, has ... photonics . Hainsey will serve as the society’s Science ... Dr. Hainsey join SPIE as our Technology Strategist, further ...
Breaking Biology Technology:Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... 4, 2011 Kylin Therapeutics, Inc., a leading ... received a notice of allowance from United States ... U.S. patent application. This newly allowed patent broadly ... expanded areas on Kylin,s proprietary nanoparticle technology platform, ...
... DIEGO, Oct. 4, 2011 Sequenom, Inc. (NASDAQ: ... genetic analysis solutions, today announced the launch of its ... genes associated with drug absorption, distribution, metabolism, and excretion ... set of pre-designed single nucleotide polymorphisms (SNP), insertions and ...
... October 4, 2011 Funds to Advance ... a clinical stage European biotechnology company addressing unmet medical ... million ($20 million) in a Series B funding round ... Sofinnova Partners, as well as private Italian investors, joined ...
Cached Biology Technology:Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology 2Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System 2Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System 3Creabilis Raises €15M ($20M) in Series B Fundraising Round 2
(Date:7/9/2014)... is one of the amphibians with the highest distribution ... areas of water where it comes into contact with ... Research carried out by the Spaniard Germn Orizaola from ... of these frogs have developed a defensive response to ... larger bodies if they co-exist with the crayfish. , ...
(Date:7/9/2014)... laboratory testing, countless measurement results accrue. To completely ... extremely time consuming. In fact, researchers in the ... managing data, according to an online survey of ... the Fraunhofer Institute for Applied Information Technology FIT ... that they have no centralized or structured approach ...
(Date:7/9/2014)... can alleviate the symptoms of Alzheimer,s disease, ... and effectively scavenge amyloid beta peptide in ... reduced and eliminated Aβ deposition in an ... significantly improved behavioral and cognitive impairment. Dr. ... Hospital of China Medical University, China immunized ...
Breaking Biology News(10 mins):Frogs have developed rapid defences against the red swamp crayfish 2Frogs have developed rapid defences against the red swamp crayfish 3Managing the data jungle 2Managing the data jungle 3
... State University scientists and colleagues have completed the genome ... most common and destructive plant parasites - Meloidogyne ... as the northern root-knot nematode. The research could ... to manage the ubiquitous parasitic worm, which, along with ...
... -- Florida State University,s Center for Advanced Power Systems ... to transform the nation,s electric power systems. CAPs is ... of 69 leading companies and academic institutions whose goal ... effort to increase the safety, reliability and capacity of ...
... , Plants that grow more slowly stay ... Biology, scientists at the Max Planck Institute for Developmental ... of genes, so-called microRNAs, coordinate growth and aging processes ... TCP transcription factors. These transcription factors in turn influence ...
Cached Biology News:NC State researchers get to root of parasite genome 2NC State researchers get to root of parasite genome 3FSU joins coalition working to improve nation's power grid 2Formula discovered for longer plant life 2
... Medium is formuatled for the growth ... and Sf21 cells. Grace's Insect Mediu, ... it does not contain lactalbumin hydrosylate, ... transfection. Grace's Insect Medium, Supplemented is ...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
...
...
Biology Products: